IBO AMEX
Impact BioMedical Inc.
1W: +13.2%
1M: -34.0%
3M: -31.2%
YTD: -43.4%
1Y: -50.1%
$3.55
-0.18 (-4.83%)
Weekly Expected Move ±19.8%
$2
$3
$4
$4
$5
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -7.38.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2024-01-22
Earliest Filing
2025-06-23
Latest Filing
partner: 4
investor: 2
customer: 1
Counterparties (Filed by IBO)
7 relationshipsCompanies named in IBO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Impact BioMedical Inc. | IBO | partner | Target company in the merger agreement. | 2025-06-23 | View |
| Dr. Ashleys Limited | — | partner | Parent company (PubCo) in the merger agreement. | 2025-06-23 | View |
| Dr Ashleys Bio Labs Limited | — | partner | Company being acquired in the merger agreement. | 2025-06-23 | View |
| Dr Ashleys Nevada Sub, Inc. | — | partner | Merger Sub entity in the merger agreement. | 2025-06-23 | View |
| DSS, Inc. | DSS | investor | Stockholder of Impact and signatory to the Support Agreement. | 2025-06-23 | View |
| DSS PureAir, Inc. | — | investor | Stockholder of Impact and signatory to the Support Agreement. | 2025-06-23 | View |
| Impact Biomedical, Inc. | IBO | customer | Borrower in an amended and restated promissory note agreement | 2024-01-22 | View |
Recent 8-K Filings (17)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-09 | Bylaws Amendment; Exhibits | View | |
| 2026-09-17 | Regulation FD; Exhibits | View | |
| 2026-09-15 | Regulation FD; Exhibits | View | |
| 2026-03-04 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-10-27 | Other Events | View | |
| 2025-07-28 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-06-23 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-04-03 | Entry into Material Definitive Agreement | Agreement | View |
| 2025-03-28 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-03-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-01-29 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-11-04 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-10-08 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-09-17 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-06-07 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-01-22 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR